Insulin dosing strategies to prevent hypoglycemia were the focus of previous studies in which reduced doses resulted in fewer hypoglycemic episodes without significantly reducing treatment efficacy, even in patients with reduced kidney function [36,43,44]. This evidence concerns the gene INS and Hypoglycemia.